James Shin
Stock Analyst at Deutsche Bank
(0)
# 4726
Out of 5,328 analysts
21
Total ratings
44.44%
Success rate
-22.19%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GILD Gilead Sciences | Upgrades: Buy | 80 120 | 103.22 | 16.26% | 2 | Feb 18, 2025 | |
MRK Merck & Co | Downgrades: Hold | 128 105 | 83.31 | 26.04% | 2 | Feb 18, 2025 | |
LLY Eli Lilly | Maintains: Buy | 1025 1015 | 794.79 | 27.71% | 4 | Nov 4, 2024 | |
AMGN Amgen | Reiterates: Hold | 310 305 | 283.67 | 7.52% | 2 | Aug 7, 2024 | |
INCY Incyte | Maintains: Hold | 55 60 | 62.09 | -3.37% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 53 45 | 49.49 | -9.07% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 60 | 34 | 76.47% | 1 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 150 | 193.41 | -22.44% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 800 | 588.6 | 35.92% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.34 | 646.27% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 1.06 | 1032.08% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 1.09 | 6322.02% | 1 | Dec 12, 2022 |